Abivax SA American Depositary Shares

Yahoo Finance • 2 days ago

Qualcomm, Booking Holdings upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Loop Capital upgraded Qualcomm (QCOM)... Full story

Yahoo Finance • 5 days ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 22 abstracts presented at European Crohn’s and Colitis Organization’s (... Full story

Yahoo Finance • 12 days ago

Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress

On February 13, 2026, Affinity Asset Advisors disclosed a new position in Praxis Precision Medicines(NASDAQ:PRAX), acquiring 185,000 shares in an estimated $54.53 million trade. What happened According to a SEC filing dated February 13,... Full story

Yahoo Finance • 12 days ago

Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million

On February 13, 2026, Affinity Asset Advisors disclosed a purchase of 61,500 shares of Apogee Therapeutics(NASDAQ:APGE), an estimated $3.87 million trade based on quarterly average pricing. What happened According to an SEC filing dated... Full story

Yahoo Finance • 24 days ago

ABIVAX Société Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the 11 Best Performing Stocks in the Last 12 Months.ABIVAX Société Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs A dose bottle of the medic... Full story

Yahoo Finance • 2 months ago

Is ABIVAX Société Anonyme (ABVX) One of the Hottest Large-Cap Stocks of 2025?

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the hottest large-cap stocks of 2025. On December 16, Piper Sandler raised the firm’s price target on Abivax to $142 from $112, while maintaining an Overweight rating on the shares. On the sa... Full story

Yahoo Finance • 2 months ago

Here are the most and least likely M&A targets in biotech, according to Truist

[M&A - concept waiting for mergers and acquisitions.3D rendering on yellow background.] French biotech (ABVX [https://seekingalpha.com/symbol/ABVX]) has emerged as the most likely acquisition target among biotechs in 2026, significantly o... Full story

Yahoo Finance • 2 months ago

Sector Update: Health Care Stocks Higher Late Afternoon

Health care stocks advanced late Monday afternoon with the NYSE Health Care Index rising 0.6% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

Health care stocks advanced Monday afternoon, with the NYSE Health Care Index up 0.5% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 2 months ago

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?

Key Points Cormorant Asset Management added 251,600 shares in Rapport Therapeutics; the reported position value increased by approximately $61.38 million over the prior quarter. The change represents 0.31% of Cormorant’s reportable 13F as... Full story

Yahoo Finance • 2 months ago

Abivax soars on report of Eli Lilly meeting French officials over possible deal

Investing.com -- Abivax shares jumped after fresh media reports revived speculation that U.S. drugmaker Eli Lilly is exploring a takeover of the French biotech company. The stock was up 9% in Paris by 04:21 ET (09:21 GMT) on Monday, while... Full story

Yahoo Finance • 2 months ago

Biggest stock movers Monday: ABVX, RKLB, and more

[Abstract Finance Technology Concept] koto_feja Stock futures edged up Monday morning, signaling a positive open amid year-end rally momentum and holiday-shortened trading. Here are some of Monday's biggest stock movers: BIGGEST STOCK G... Full story

Yahoo Finance • 2 months ago

Abivax to be Added to Nasdaq Biotechnology Index

Abivax to be Added to Nasdaq Biotechnology Index PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused... Full story

Yahoo Finance • 2 months ago

Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight

The ulcerative colitis market is experiencing steady growth driven by rising disease prevalence and increasing diagnosis rates worldwide. Expanding adoption of advanced biologics, small-molecule therapeutics, and targeted immunomodulators... Full story

Yahoo Finance • 2 months ago

Abivax GAAP EPS of -€2.10

* Abivax press release [https://seekingalpha.com/filing/78948133] (ABVX [https://seekingalpha.com/symbol/ABVX]): Q3 GAAP EPS of -€2.10 * Based on the above, management has concluded that its existing cash and cash equivalents are suffi... Full story

Yahoo Finance • 2 months ago

Earnings week ahead: FDX, NKE, MU, BB, CCL, ACN, and more

[Business.] artisteer/iStock via Getty Images The upcoming week may be a quiet one for earnings reports, but several notable companies are poised to grab investor attention. Tech stalwart BlackBerry (BB [https://seekingalpha.com/symbol/B... Full story

Yahoo Finance • 3 months ago

2 Under-the-Radar Stocks That Have Soared This Year

Key Points TransMedics Group's revolutionary organ care system is driving its strong results. Abivax is a David among Goliaths, and its growth story might just be getting started. 10 stocks we like better than TransMedics Group › Lookin... Full story

Yahoo Finance • 3 months ago

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy?

Key Points Austin-based Saturn V Capital Management acquired 886,332 shares of Pharvaris in the third quarter. Saturn V now holds 886,332 PHVS shares valued at $22.1 million. PHVS is a new addition, accounting for 4.9% of 13F AUM, which p... Full story

Yahoo Finance • 3 months ago

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow?

Key Points Austin-based Saturn V Capital Management added 1.3 million shares of Amylyx Pharmaceuticals in the third quarter. The overall position increased in value by $41.2 million from quarter to quarter. Saturn V now holds 4.6 million... Full story

Yahoo Finance • 3 months ago

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets

Key Points Austin-based Saturn V Capital Management added 1.2 million shares of Dyne Therapeutics during the third quarter. The overall position increased in value by $20 million from quarter to quarter. Saturn V now holds nearly 2.7 mill... Full story